THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 30 filers reported holding THERAVANCE INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,442 | -100.0% | 2,450,000 | -55.0% | 0.00% | -55.6% |
| Q3 2022 | $5,336,000 | -1.8% | 5,450,000 | 0.0% | 0.01% | -10.0% |
| Q2 2022 | $5,436,000 | -9.0% | 5,450,000 | 0.0% | 0.01% | +11.1% |
| Q1 2022 | $5,973,000 | +64.1% | 5,450,000 | +62.7% | 0.01% | +80.0% |
| Q4 2021 | $3,639,000 | +52.0% | 3,350,000 | +34.0% | 0.01% | -16.7% |
| Q3 2020 | $2,394,000 | -76.1% | 2,500,000 | 0.0% | 0.01% | -76.0% |
| Q2 2020 | $9,998,000 | +328.5% | 2,500,000 | 0.0% | 0.02% | +257.1% |
| Q1 2020 | $2,333,000 | – | 2,500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $1 | 0.00% |